NCM · Medical - Devices
HYPD (HYPD) Stock
$2.64
-0.75%
NCM: HYPD
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Hyperion Deploys 500,000 HYPE to Back Skew’s HIP-3 Market Push
CryptoProwl · Jul 16, 2026
Hyperion DeFi Taps Blockdaemon to Expand Hyperliquid Staking Infrastructure
CryptoProwl · Jun 22, 2026
Hyperion CEO Says HYPE Rally Still Undervalues Hyperliquid’s Ecosystem Shift
CryptoProwl · Jun 18, 2026
Chardan Adjusts Hyperion DeFi Price Target to $7.30 From $8.25, Maintains Buy Rating
MT Newswires · Jun 8, 2026
Hyperion DeFi Inc (HYPD) Q1 2026 Earnings Call Highlights: Strong Growth Amidst Token Volatility
GuruFocus.com · May 14, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held14.10%
Institutions Held11.39%
Institutions Float Held13.26%
Peer Comparison
About HYPD
HYPD is led by CEO Hyunsu Jung, employs 13 people, headquartered in US, publicly traded since 2025.
HYPD stock trades at $2.64 with a market capitalization of $13.17M. The stock is valued at a price-to-earnings (P/E) ratio of -0.40, price-to-book of 0.46, price-to-sales of 18.09. Over the past 52 weeks the stock has ranged between $2.49 and $17.18, and currently trades 84.6% below its 52-week high.
On profitability, HYPD generates a return on equity (ROE) of -109.76%, return on capital employed of -46.34%, an operating margin of -1900.00%, a net profit margin of -31.63%.